26.73USD+6.24%Mkt Cap: 1.31B USDP/E: —Last update: 2026-06-01
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The…
Industry Peers
Medical Instruments & Supplies146.01BUSDP/E 50.0
86.09BDKKP/E 40.9
79.36BEURP/E 34.8
40.39BUSDP/E 25.6
30.12BUSDP/E 31.2
27.29BUSDP/E 18.1
25.22BCHFP/E 39.2
22.10BUSDP/E 41.8
Indicators:|
Key Statistics
Company
Market Cap1.31B USD
Enterprise Value1.15B USD
Revenue (TTM)101.66M USD
Gross Profit62.12M USD
Net Income (TTM)-4.59M USD
Revenue/Share2.114 USD
Last Price26.73 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees155
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)85.93
PEG15.09
EV/EBITDA266.46
EV/Revenue11.33
P/S11.98
P/B3.27
EPS (TTM)-0.24
EPS (Forward)0.29
52W Range
17.8675% of range29.62
52W High29.62 USD
52W Low17.86 USD
Profitability
Gross Margin64.56%
Oper. Margin0.10%
EBITDA Margin4.25%
Profit Margin-4.78%
ROE-1.24%
ROA-1.13%
Growth
Revenue Growth24.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF20.11M USD
CapEx (TTM)19.70M USD
FCF Margin6.29%
FCF Yield0.49%
Net Debt-66.14M USD
Net Debt/EBITDA-15.31
Balance Sheet
Debt/Equity0.05
Current Ratio7.30
Quick Ratio5.15
Book Value/Sh7.624 USD
Cash/Share1.658 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:14
Split DateJan 29, 2014
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)32.30 USD
Target Range30.00 USD – 34.00 USD
# Analysts10
Ownership
Shares Out.48.86M
Float42.84M
Insiders2.39%
Institutions104.35%
Short Interest
Short Ratio10.0d
Short % Float12.10%
Short % Out.7.73%
Shares Short3.78M
Short (prev mo.)3.33M
Technical
SMA 5021.11 (+26.6%)
SMA 20023.87 (+12.0%)
Beta1.97
S&P 52W Chg27.94%
Avg Vol (30d)511.53K
Avg Vol (10d)812.81K
Technical Indicators
RSI (14)65.8
MACD1.0171
MACD Signal0.7276
MACD Hist.+0.2895
BB Upper25.75 USD
BB Middle22.67 USD
BB Lower19.60 USD
BB Width27.11%
ATR (14)1.115 USD
Vol Ratio (20d)0.57x